A Comparison of Sustained and Extended Release Bupropion Following Bariatric Surgery

Trial Profile

A Comparison of Sustained and Extended Release Bupropion Following Bariatric Surgery

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 Apr 2016

At a glance

  • Drugs Bupropion (Primary)
  • Indications Major depressive disorder; Seasonal affective disorder; Smoking withdrawal
  • Focus Pharmacokinetics
  • Most Recent Events

    • 04 Apr 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 11 May 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
    • 25 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top